These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26574539)

  • 21. Diabetes mellitus in amyotrophic lateral sclerosis: Dr. Jekyll or Mr. Hyde?
    Jawaid A; Brown JA; Schulz PE
    Eur J Neurol; 2015 Nov; 22(11):1419-20. PubMed ID: 25597340
    [No Abstract]   [Full Text] [Related]  

  • 22. Validity of medico-administrative data related to amyotrophic lateral sclerosis in France: A population-based study.
    Vasta R; Boumédiene F; Couratier P; Nicol M; Nicoletti A; Preux PM; Marin B;
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):24-31. PubMed ID: 27797285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA.
    Caller TA; Field NC; Chipman JW; Shi X; Harris BT; Stommel EW
    Amyotroph Lateral Scler; 2012 Jan; 13(1):25-32. PubMed ID: 22214351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin use and risk of amyotrophic lateral sclerosis and other motor neuron disorders.
    Sørensen HT; Riis AH; Lash TL; Pedersen L
    Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):413-7. PubMed ID: 20530788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Am J Public Health; 2015 Jun; 105(6):e7-9. PubMed ID: 25970478
    [No Abstract]   [Full Text] [Related]  

  • 26. The epidemiology of ALS and the role of population-based registries.
    Beghi E; Logroscino G; Chiò A; Hardiman O; Mitchell D; Swingler R; Traynor BJ;
    Biochim Biophys Acta; 2006; 1762(11-12):1150-7. PubMed ID: 17071060
    [No Abstract]   [Full Text] [Related]  

  • 27. Physical Trauma and Amyotrophic Lateral Sclerosis: A Population-Based Study Using Danish National Registries.
    Seals RM; Hansen J; Gredal O; Weisskopf MG
    Am J Epidemiol; 2016 Feb; 183(4):294-301. PubMed ID: 26825926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantifying a nonnotifiable disease in the United States: the National Amyotrophic Lateral Sclerosis Registry model.
    Horton DK; Mehta P; Antao VC
    JAMA; 2014 Sep; 312(11):1097-8. PubMed ID: 25057819
    [No Abstract]   [Full Text] [Related]  

  • 29. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia.
    Elamin M; Phukan J; Bede P; Jordan N; Byrne S; Pender N; Hardiman O
    Neurology; 2011 Apr; 76(14):1263-9. PubMed ID: 21464431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyotrophic lateral sclerosis in Piedmont (Italy): a Bayesian spatial analysis of the incident cases.
    Migliaretti G; Berchialla P; Dalmasso P; Cavallo F; Chiò A
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Jan; 14(1):58-65. PubMed ID: 23134503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cluster of amyotrophic lateral sclerosis.
    Melmed C; Krieger C
    Arch Neurol; 1982 Sep; 39(9):595-6. PubMed ID: 7115153
    [No Abstract]   [Full Text] [Related]  

  • 33. Association between alcohol consumption and amyotrophic lateral sclerosis: a meta-analysis of five observational studies.
    E M; Yu S; Dou J; Jin W; Cai X; Mao Y; Zhu D; Yang R
    Neurol Sci; 2016 Aug; 37(8):1203-8. PubMed ID: 27103621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study.
    Burke T; Pinto-Grau M; Lonergan K; Elamin M; Bede P; Costello E; Hardiman O; Pender N
    PLoS One; 2016; 11(8):e0160850. PubMed ID: 27556398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of demographic factors on survival time after a diagnosis of amyotrophic lateral sclerosis.
    Jordan H; Fagliano J; Rechtman L; Lefkowitz D; Kaye W
    Neuroepidemiology; 2015; 44(2):114-20. PubMed ID: 25792423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 148th ENMC international workshop on the scientific contributions of the EURALS consortium on amyotrophic lateral sclerosis.
    Beghi E; Pupillo E; Zoccolella S;
    Neuromuscul Disord; 2009 May; 19(5):379-81. PubMed ID: 19345585
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997-2007.
    Marin B; Gil J; Preux PM; Funalot B; Couratier P
    Amyotroph Lateral Scler; 2009 Aug; 10(4):216-20. PubMed ID: 19452307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Climatic factors associated with amyotrophic lateral sclerosis: a spatial analysis from Taiwan.
    Tsai CP; Tzu-Chi Lee C
    Geospat Health; 2013 Nov; 8(1):45-52. PubMed ID: 24258882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amyotrophic lateral sclerosis occuring befor the age of 40 years. Remarks apropos of 25 cases].
    Aimard G; Bady B; Boisson D; Trouillas P; Devic M
    Rev Neurol (Paris); 1976 Aug; 132(8):563-6. PubMed ID: 981861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative analysis of the epidemiology of amyotrophic lateral sclerosis in the province of Poznan].
    Wender M; Pruchnik D; Kowal P; Florczak J
    Neurol Neurochir Pol; 1990; 24(5-6):297-302. PubMed ID: 2131426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.